CUA Educational Content

Prostate Cancer Care Debate: Navigating Evidence and Opinions in Advanced CSPC Management

Speakers: Nimira Alimohamed, Tamim Niazi, Bobby Shayegan & Christopher Wallis

Objectives

By the end of this program, participants can expect to:

  • Apply emerging evidence to guide treatment intensification decisions in high-risk BCR and mCSPC
  • Evaluate the balance between early treatment intensification, patient outcomes, and quality of life
  • Determine the optimal timing and role of PSMA-PET in treatment decision-making
  • Identify best practices for combining RT, ADT, and/or ARPI to optimize patient outcomes
Start Quiz for Credits

ACCREDITATION

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.

-------------------------------------

This program has received financial support from Astellas in the form of an educational grant.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy